Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in pediatric hypertension
NCT00147615Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2004
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 3, open-label, single-arm trial of eplerenone in hypertension (HTN), sponsored by Viatris. Primary endpoint: Safety of eplerenone at 52 weeks. Started Oct 2004; status: completed.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00147615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147615.